Terapet
Terapet develops advanced gamma-ray detection systems and PET-based imaging solutions for treatment verification in particle therapy and nuclear medicine. Its product portfolio includes the QUALYSCAN and NUCLYSCAN systems, which enable clinicians to measure treatment-induced activity and perform patient-specific quality assurance. These technologies are designed for hospitals, research institutes, and clinical trials to bridge the gap between treatment planning and actual beam delivery.
Healthtech
Medical Devices
Oncology
Nuclear Medicine
Funding summary
- Total raised
- €2.6M
- Funding rounds
- 3
Investors in Terapet
Investors on record for Terapet. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Terapet?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors